Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Regenerx Biopharmaceuticals Inc (RGRX)

Regenerx Biopharmaceuticals Inc (RGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Regenerx Biopharmaceuticals Inc 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 USA

www.regenerx.com P: 301-208-9191

Description:

RegeneRx is a biopharmaceutical company that holds over fifty world-wide patents and patent applications related to dermal, ocular, and internal wounds and tissue repair, including the treatment and prevention of cardiac and neurological injuries.

Key Statistics

Overview:

Market Capitalization, $K 79
Enterprise Value, $K -211
Shares Outstanding, K 1,509
Annual Sales, $ 80 K
Annual Net Income, $ -1,730 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -390 K
EBIT, $ -1,350 K
EBITDA, $ -1,350 K
60-Month Beta 2.57
% of Insider Shareholders 12.60%
% of Institutional Shareholders 0.00%
Float, K 1,319
% Float 87.40%
Short Volume Ratio 0.00

Growth:

1-Year Return -99.49%
3-Year Return -99.93%
5-Year Return -99.59%
5-Year Revenue Growth 33.33%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 01/02/23
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 10/18/23

RGRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -2,162.50%
Debt/Equity 0.00
Price/Sales 0.99
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.60
Interest Coverage -4.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar